Resmed – Algo Buy
ResMed is under Algo Engine buy conditions and we see buying support building.
ResMed will release 2Q21 earnings on Friday 29 January.

ResMed is under Algo Engine buy conditions and we see buying support building.
ResMed will release 2Q21 earnings on Friday 29 January.
ASX is under Algo Engine buy conditions and is now likely to find buying support.
Ansell is under Algo Engine buy conditions and we see support building within the $33 – $36 level.
ANN goes ex-div $0.33 on 24 Feb.
Subscribers to our Options Pro service should look at buying the Feb $34.50 calls as a leveraged exposure. For more detail on our strategy, please call 1300 614 002.
Amcor is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Amcor goes ex-div $0.17 on 3 March.
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our model portfolio.
{NYS:C} reported Q4 earnings which showed a 10% fall in revenue and 7% fall in profit.
The release of $1.5bn in reserves for credit losses helps to pad the numbers, as did the potential one-off boost from growth in trading and investment-related income.
In 2021 we remain concerned about credit quality deterioration and risks to non-repeatable investment-related income growth, both likely to negatively impact returns.
The company share buyback program will offer some downside protection and we’ll look to enter the trade from the long side, at lower price levels.
For the time being, we sit on the short side of the Citi trade.
Coles Group is under Algo Engine buy conditions.
Monitor Coles for a swing higher in the short-term momentum indicators within the price zone displayed below.
Vanguard Global Infrastructure Index is in our “high conviction” portfolio.
We see upside from the current $53 price level.
The fund offers investors diversified exposure to infrastructure sectors, including transportation, energy and telecommunications.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
NCM is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
We see price support developing near the $25 – $26 level.
Or start a free thirty day trial for our full service, which includes our ASX Research.